Corteva (NYSE:CTVA) Price Target Raised to $80.00

Corteva (NYSE:CTVA) had its price objective increased by CICC Research from $70.00 to $80.00 in a report issued on Wednesday morning,MarketScreener reports. They currently have an outperform rating on the stock.

A number of other equities research analysts also recently issued reports on CTVA. Oppenheimer set a $86.00 price objective on shares of Corteva in a research report on Thursday, February 5th. Royal Bank Of Canada upped their target price on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. Wells Fargo & Company boosted their price objective on Corteva from $77.00 to $85.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, UBS Group lowered Corteva from a “buy” rating to a “hold” rating in a research note on Monday. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and a consensus price target of $82.20.

Corteva Trading Up 1.2%

Shares of Corteva stock opened at $74.98 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a market cap of $50.67 billion, a price-to-earnings ratio of 47.46, a PEG ratio of 2.52 and a beta of 0.75. Corteva has a twelve month low of $53.40 and a twelve month high of $77.41. The business has a 50-day moving average price of $69.67 and a 200-day moving average price of $68.46.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The company had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the company earned $0.32 earnings per share. The firm’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts anticipate that Corteva will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio is currently 45.57%.

Institutional Investors Weigh In On Corteva

Institutional investors and hedge funds have recently modified their holdings of the business. Chilton Capital Management LLC lifted its position in Corteva by 18.1% during the third quarter. Chilton Capital Management LLC now owns 445,350 shares of the company’s stock worth $30,119,000 after buying an additional 68,380 shares in the last quarter. TriaGen Wealth Management LLC acquired a new stake in shares of Corteva in the 3rd quarter worth $4,284,000. New York State Teachers Retirement System raised its holdings in shares of Corteva by 4.5% during the 3rd quarter. New York State Teachers Retirement System now owns 551,389 shares of the company’s stock worth $37,290,000 after acquiring an additional 23,548 shares during the period. Truist Financial Corp boosted its position in shares of Corteva by 4.5% during the 3rd quarter. Truist Financial Corp now owns 321,913 shares of the company’s stock valued at $21,771,000 after acquiring an additional 13,910 shares during the last quarter. Finally, Nordea Investment Management AB grew its holdings in shares of Corteva by 27.4% in the third quarter. Nordea Investment Management AB now owns 75,675 shares of the company’s stock valued at $5,103,000 after purchasing an additional 16,261 shares during the period. 81.54% of the stock is owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.